JP2021528449A5 - - Google Patents

Info

Publication number
JP2021528449A5
JP2021528449A5 JP2020571762A JP2020571762A JP2021528449A5 JP 2021528449 A5 JP2021528449 A5 JP 2021528449A5 JP 2020571762 A JP2020571762 A JP 2020571762A JP 2020571762 A JP2020571762 A JP 2020571762A JP 2021528449 A5 JP2021528449 A5 JP 2021528449A5
Authority
JP
Japan
Prior art keywords
compound according
spp
residue
compound
leucine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020571762A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021528449A (ja
JP7488774B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/066819 external-priority patent/WO2020002325A1/en
Publication of JP2021528449A publication Critical patent/JP2021528449A/ja
Publication of JP2021528449A5 publication Critical patent/JP2021528449A5/ja
Priority to JP2024077064A priority Critical patent/JP2024109664A/ja
Application granted granted Critical
Publication of JP7488774B2 publication Critical patent/JP7488774B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020571762A 2018-06-25 2019-06-25 化合物 Active JP7488774B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024077064A JP2024109664A (ja) 2018-06-25 2024-05-10 化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862689602P 2018-06-25 2018-06-25
US62/689,602 2018-06-25
PCT/EP2019/066819 WO2020002325A1 (en) 2018-06-25 2019-06-25 Compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024077064A Division JP2024109664A (ja) 2018-06-25 2024-05-10 化合物

Publications (3)

Publication Number Publication Date
JP2021528449A JP2021528449A (ja) 2021-10-21
JP2021528449A5 true JP2021528449A5 (https=) 2022-07-07
JP7488774B2 JP7488774B2 (ja) 2024-05-22

Family

ID=67107423

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020571762A Active JP7488774B2 (ja) 2018-06-25 2019-06-25 化合物
JP2024077064A Pending JP2024109664A (ja) 2018-06-25 2024-05-10 化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024077064A Pending JP2024109664A (ja) 2018-06-25 2024-05-10 化合物

Country Status (31)

Country Link
US (3) US11459357B2 (https=)
EP (2) EP3810633B1 (https=)
JP (2) JP7488774B2 (https=)
KR (1) KR20210054500A (https=)
CN (2) CN112789287B (https=)
AR (1) AR116663A1 (https=)
AU (2) AU2019294261B2 (https=)
BR (1) BR112020026663A2 (https=)
CA (1) CA3103158A1 (https=)
CO (1) CO2020016080A2 (https=)
DK (1) DK3810633T3 (https=)
EA (1) EA202092819A1 (https=)
ES (1) ES2971732T3 (https=)
FI (1) FI3810633T3 (https=)
HR (1) HRP20240028T1 (https=)
HU (1) HUE065134T2 (https=)
IL (2) IL279620B2 (https=)
LT (1) LT3810633T (https=)
MA (1) MA52946B1 (https=)
MD (1) MD3810633T2 (https=)
MX (1) MX2020013811A (https=)
PH (1) PH12020552240A1 (https=)
PL (1) PL3810633T3 (https=)
PT (1) PT3810633T (https=)
RS (1) RS65128B1 (https=)
SG (1) SG11202012747VA (https=)
SI (1) SI3810633T1 (https=)
TW (2) TW202446783A (https=)
UA (1) UA128162C2 (https=)
WO (1) WO2020002325A1 (https=)
ZA (1) ZA202301937B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107108699A (zh) 2014-11-26 2017-08-29 新药物许可控股有限公司 化合物
MD3810633T2 (ro) * 2018-06-25 2024-05-31 Spero Therapeutics Inc Compuşi
TW202233649A (zh) 2020-11-06 2022-09-01 美商斯佩羅治療學股份有限公司 化合物
WO2022262823A1 (zh) * 2021-06-18 2022-12-22 华南理工大学 活性氧自由基响应的多粘菌素前药化合物及其应用
CN120574287A (zh) * 2025-06-10 2025-09-02 中国药科大学 一种抗菌肽、组合物及应用
CN120518715B (zh) * 2025-07-24 2025-10-03 中国药科大学 一种抗菌肽、药物组合物及应用
CN120699105B (zh) * 2025-08-19 2025-11-21 中国药科大学 一种氘代抗菌肽及其组合物和应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2128617A (en) 1982-10-06 1984-05-02 Martti Vaara Polypeptides for use in antibacterial therapy
WO1988000950A2 (fr) 1986-08-06 1988-02-11 Fauchere Jean Luc Fabrication de conjugues a liaisons de covalence a partir d'un antibiotique et d'un derive non toxique de la polymyxine b
US20010021697A1 (en) 1987-09-14 2001-09-13 Henning Lowenstein Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinageous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
TW274552B (https=) 1992-05-26 1996-04-21 Hoechst Ag
US5767068A (en) 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
AU2004277977B2 (en) 2003-09-30 2010-10-28 Biomechanisms Inc. Compositions and methods for treating burns
US20060004185A1 (en) 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
US7807637B2 (en) 2006-08-11 2010-10-05 Northern Antibiotics Oy Polymyxin derivatives and uses thereof
HUE028271T2 (en) 2006-08-11 2016-12-28 Northern Antibiotics Oy Polymixin derivatives and their applications
FI20085469A0 (fi) 2008-02-08 2008-05-16 Northern Antibiotics Oy Polymyksiinijohdannaiset, joissa on lyhyt rasvahappohäntä, ja niiden käyttöjä
US8193148B2 (en) 2008-02-08 2012-06-05 Northern Antibiotics Ltd. Short fatty acid tail polymyxin derivatives and uses thereof
US8329645B2 (en) 2008-02-08 2012-12-11 Northern Antibiotics Ltd. Polymyxin derivatives and uses thereof
ES2334547B1 (es) 2008-09-10 2010-12-03 Universidad De Barcelona Compuestos peptidicos antibacterianos.
TW201035111A (en) 2008-12-23 2010-10-01 Biosource Pharm Inc Antibiotic compositions for the treatment of gram negative infections
CN101851270A (zh) 2009-04-03 2010-10-06 梁浩 一种多粘菌素衍生物及其制备方法
WO2010130007A1 (en) 2009-05-14 2010-11-18 Monash University Antimicrobial compounds
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
WO2012051663A1 (en) 2010-10-21 2012-04-26 Monash University Antimicrobial compounds
WO2012168820A1 (en) * 2011-06-08 2012-12-13 Pfizer Inc. Polymyxin derivatives useful as antibacterial agents
BR112014012016A2 (pt) 2011-11-18 2017-05-16 Cantab Anti-Infectives Ltd compostos
JP6643758B2 (ja) 2013-05-22 2020-02-12 スペロ・セラピューティクス・インコーポレーテッド 異なった抗生物質と一緒の組合せ療法におけるポリミキシン誘導体及びその使用
RU2740190C2 (ru) 2014-03-11 2021-01-12 Сперо Терапьютикс, Инк. Производные полимиксина и их применение в комбинированной терапии совместно с различными антибиотиками
US10047126B2 (en) 2014-04-01 2018-08-14 Monash University Polymyxin derivatives as antimicrobial compounds
CN107108699A (zh) 2014-11-26 2017-08-29 新药物许可控股有限公司 化合物
KR20170098821A (ko) * 2014-12-17 2017-08-30 에프. 호프만-라 로슈 아게 소르타아제를 사용한 １ 단계로의 이중 폴리펩티드 컨쥬게이션을 위한 효소 원-포트 반응
WO2016166103A1 (en) * 2015-04-13 2016-10-20 Xellia Pharmaceuticals Aps Polymyxin derivatives
EP3356387B1 (en) * 2015-09-29 2024-06-26 Monash University Antimicrobial polymyxin derivative compounds
AU2017285424B2 (en) * 2016-06-16 2022-08-18 International Aids Vaccine Initiative, Inc. Tuberculosis compositions and methods of treating or preventing tuberculosis
MD3810633T2 (ro) * 2018-06-25 2024-05-31 Spero Therapeutics Inc Compuşi
WO2020014501A1 (en) 2018-07-11 2020-01-16 Cidara Therapeutics, Inc. Compositions and methods for the treatment of bacterial infections

Similar Documents

Publication Publication Date Title
JP2021528449A5 (https=)
HRP20240028T1 (hr) Spojevi
JP2014533678A5 (https=)
MY192109A (en) Aminopyrimidinyl compounds as jak inhibitors
HRP20220387T1 (hr) Derivati polimiksina i njihova upotreba u kombinacijskoj terapiji zajedno s različitim antibioticima
HRP20221217T1 (hr) Spojevi inhibitori beta-laktamaze
JP2011513305A5 (https=)
JP2015527387A5 (https=)
JP2009544602A5 (https=)
JP2015535847A5 (https=)
JP2019516713A5 (https=)
JP2021523241A5 (https=)
JP2016503778A5 (https=)
JP2016501864A5 (https=)
JP2019519512A5 (https=)
JP2017538692A5 (https=)
JP2018500387A5 (https=)
JP2016528257A5 (https=)
JP2019502659A5 (https=)
JP2019501123A5 (https=)
JP2019501896A5 (https=)
JP2018523675A5 (https=)
CN106660962A (zh) 用作选择性抗菌剂的含2‑吡啶酮部分的芳基酰肼
JP2017521367A5 (https=)
GB2584009A (en) Aminoglycosides and uses thereof